As of January 22, 2025, Minerva Neurosciences (NERV) has a market cap of $14.756 million USD. According to our data, Minerva Neurosciences is ranked No.8722 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $14.76 M |
-5.04%
|
Dec 31, 2024 | $15.54 M |
-63.87%
|
Dec 29, 2023 | $43.01 M |
286.79%
|
Dec 30, 2022 | $11.12 M |
-75.19%
|
Dec 31, 2021 | $44.81 M |
-65.77%
|
Dec 31, 2020 | $0.13 B |
-67.09%
|
Dec 31, 2019 | $0.40 B |
5.49%
|
Dec 31, 2018 | $0.38 B |
11.40%
|
Dec 29, 2017 | $0.34 B |
-48.51%
|
Dec 30, 2016 | $0.66 B |
93.57%
|
Dec 31, 2015 | $0.34 B |
0.83%
|
Dec 31, 2014 | $0.34 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
ACADIA Pharmaceuticals
ACAD
|
$2.96 B |
-0.000 M
|
USA
|
Alkermes
ALKS
|
$4.89 B |
-0.000 M
|
Ireland
|
Axsome Therapeutics
AXSM
|
$4.96 B |
0.000 M
|
USA
|
Biohaven Pharmaceutical
BHVN
|
$4.10 B |
-0.000 M
|
USA
|
Intra-Cellular Therapies
ITCI
|
$13.51 B |
-0.000 M
|
USA
|
Sage Therapeutics
SAGE
|
$0.43 B |
-0.000 M
|
USA
|
Jazz Pharmaceuticals
JAZZ
|
$7.31 B |
0.000 M
|
Ireland
|
Neurocrine Biosciences
NBIX
|
$14.86 B |
-0.000 M
|
USA
|
Corcept Therapeutics
CORT
|
$6.18 B |
0.000 M
|
USA
|
Cassava Sciences
SAVA
|
$0.12 B |
0.000 M
|
USA
|
Anavex Life Sciences
AVXL
|
$0.85 B |
0.000 M
|
USA
|
Market Cap | = | NERV Stock Price | * | NERV Shares Outstanding |
= | $2.11 | * | 6.99 M | |
= | $14.76 M |